1. Meighani A, Jafri S-MR, Raoufi M, Salgia R. Splenic Artery Embolization for Treatment of Refractory Ascites After Liver Transplantation. ACG Case Reports J. 2016; 3:136–8.
Article
2. Unger LW, Mandorfer M, Reiberger T. Portal Hypertension after Liver Transplantation — Causes and Management. Curr Hepatology Rep. 2019; 18:59–66.
3. Quintini C, D’Amico G, Brown C, Aucejo F, Hashimoto K, Kelly DM, et al. Splenic Artery Embolization for the Treatment of Refractory Ascites After Liver Transplantation. Liver Transplant. 2011; 17:668–73.
Article
4. Lee TY, Fan HL, Wang CW, Hsieh CB, Chen TW. Somatostatin Therapy in Patients with Massive Ascites After Liver Transplantation. Ann Transplant. 2019; 24:1–8.
Article
5. Luca A, Miraglia R, Caruso S, Milazzo M, Gidelli B, Bosch J. Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension. Liver Transplant. 2006; 12:1237–43.
Article
6. Presser N, Quintini C, Tom C, Wang W, Liu Q, Diago-Uso T, et al. Safety and Efficacy of Splenic Artery Embolization for Portal Hyperperfusion in Liver Transplant Recipients: A 5-Year Experience. Liver Transplant. 2015; 21:435–41.
Article
7. Grieser C, Denecke T, Steffen IG, Avgenaki M, Fröhling V, Mogl M, et al. Multidetector computed tomography for preoperative assessment of hepatic vasculature and prediction of splenic artery steal syndrome in patients with liver cirrhosis before transplantation. Eur Radiol. 2010; 20:108–17.
Article
8. Humar A, Beissel J, Crotteau S, Cohen M, Lake J, Payne WD. Delayed splenic artey occlusion for treatment of established small-for-size syndrome after partial liver transplantation. Liver Transplant. 2009; 15:163–8.
9. Troisi R, Cammu G, Militerno G, De Baerdemaeker L, Decruyenaere J, Hoste E, et al. Modulation of Portal Graft Inflow: A Necessity in Adult Living-Donor Liver Transplantation? Ann Surg. 2003; 237:429–36.
Article
10. Iranpour P, Lall C, Houshyar R, Helmy M, Yang A, Choi J Il, et al. Altered Doppler flow patterns in cirrhosis patients: An overview. Ultrasonography. 2016; 35:3–12.
Article
11. Vivek MA, Augustine A, Rao R. A comprehensive predictive scoring method for difficult laparoscopic cholecystectomy. J Minim Access Surg. 2014; 10:62–7.
12. Van der Cruyssen F, Manzelli A. Splenic artery embolization: Technically feasible but not necessarily advantageous. World J Emerg Surg. 2016; 11:1–14.
Article
13. Perkins JD. Techniques to ensure adequate portal flow in the presence of splenorenal shunts. Liver Transplant. 2007; 13:767–8.
14. Janczak DT, Mimier MK, McBane RD, Kamath PS, Simmons BS, Bott-Kitslaar DM, Lenz CJ, Vargas ER, Hodge DO, Wysokinski WE. Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location. Mayo Clin Proc. 2018; 93:40–7.
Article
15. Cheung KS, Leung WK. Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management. World J Gastroenterol. 2017; 23:1954–63.
Article
16. Chang CY, Singal AK, Ganeshan SV, Schiano TD, Lookstein R, Emre S. Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transplant. 2007; 13:1532–7.
Article